1102. COVID-19 and the Risk of CNS Demyelinating Diseases - a podcast by SRNA

For this episode of “Ask the Expert: Research Edition,” Rebecca Whitney of SRNA was joined by Dr. Michael Levy. Dr. Levy gave a brief overview of one of his recent papers with colleagues that was featured in Frontiers in Neurology, “COVID-19 and the risk of CNS demyelinating diseases: A systematic review.” For this paper, the authors reviewed literature published in English on different platforms around the world where the diagnosis was confirmed usually with aquaporin-4 or MOG antibody testing, including children and adults. They examined whether Covid infections cause inflammatory central nervous system (CNS) demyelinating diseases, including multiple sclerosis, NMOSD, MOG antibody disease, or relapses, and at what rate. You can view the paper here: https://www.frontiersin.org/articles/10.3389/fneur.2022.970383/full

Further episodes of Ask the Expert

Further podcasts by SRNA

Website of SRNA